ProStar, the World Leader in Developing Precision Mapping Solutions, Has Been Granted Another Significant Patent
27 avr. 2023 10h00 HE
|
ProStar
GRAND JUNCTION, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ProStar Holdings Inc. ("ProStar®" or the “Company") (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) a world leader in Precision Mapping Solutions®,...
Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds
26 avr. 2023 07h00 HE
|
Mindset Pharma Inc.
TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company developing novel, optimized,...
United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTI
20 avr. 2023 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
AB Science annonce l’obtention d’un brevet sur le masitinib au Japon pour le traitement de la sclérose latérale amyotrophique, renforçant ainsi la position de la société en matière de propriété intellectuelle jusqu’en 2037
18 avr. 2023 12h55 HE
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE L'OBTENTION D'UN BREVET SUR LE MASITINIB AU JAPON POUR LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE, RENFORÇANT AINSI LA POSITION DE LA SOCIÉTÉ EN...
AB Science announces masitinib patent granted in Japan for the treatment of amyotrophic lateral sclerosis, strengthening the Company’s intellectual property position until 2037
18 avr. 2023 12h55 HE
|
AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES MASITINIB PATENT GRANTED IN JAPAN FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, STRENGTHENING THE COMPANY’S INTELLECTUAL PROPERTY POSITION UNTIL 2037 TO...
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
12 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue...
Anaqua Provides Platform for Intellectual Property Management to Fujitsu
06 avr. 2023 10h23 HE
|
Anaqua
BOSTON, April 06, 2023 (GLOBE NEWSWIRE) -- Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that information and communications...
Anaqua fournit une plateforme de gestion de la propriété intellectuelle à Fujitsu
06 avr. 2023 10h23 HE
|
Anaqua
BOSTON, 06 avr. 2023 (GLOBE NEWSWIRE) -- Anaqua, le leader de l'innovation et de la gestion de la propriété intellectuelle (PI), a annoncé aujourd'hui que la société Fujitsu, spécialisée dans les...
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent
06 avr. 2023 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Nocopi Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
31 mars 2023 16h01 HE
|
Nocopi Technologies, Inc.
KING OF PRUSSIA, Pa., March 31, 2023 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks today announced results for its fourth quarter and twelve...